Related Experiment Video
Updated: Jan 18, 2026

Pooled CRISPR-Based Genetic Screens in Mammalian Cells
Published on: September 4, 2019
Pooled CRISPRi screening reveals fungal-specific vulnerabilities across environments and genetic backgrounds
Lauren F Wensing1, Philippe C Després1,2,3, Desiree Francis1
1Department of Molecular and Cellular Biology, University of Guelph, Guelph, Canada.
Abstract:
The rising rate of drug-resistant fungal infections and the emergence of fungal pathogens with intrinsic resistance phenotypes are a growing concern. The close evolutionary distance between mammals and fungi complicates the design of new antifungals and increases the chances of toxic off-target effects. As such, antifungal drug development usually focuses on fungal-specific proteins when considering potential new targets. Ideal drug targets should mediate essential cell processes and be highly sensitive to inhibition. Targeted gene repression can serve as a model for drug-mediated inhibition and for determining the dosage-sensitivity profile of genes of interest. In the fungal pathogen Candida albicans, classical approaches for gene repression can be labour-intensive and limited to one genetic background due to low throughput. Here, we adapt pooled CRISPRi screening in C. albicans for the first time and exploit this technique for large-scale functional genomic analysis. Through pooled CRISPRi screening, we test the repression sensitivity of over a hundred essential genes conserved in fungi but absent in humans, and successfully identify highly dosage-sensitive genes across multiple cell components and pathways. By extending our analysis to ten diverse environmental conditions, we show how the environment influences dosage-sensitivity profiles. Finally, we extend our experiments to two clinical drug-resistant C. albicans strain backgrounds and demonstrate that many of the fitness defects we observed are conserved in resistant clinical isolates. Together, our results highlight a set of genes that are highly dosage-sensitive across different genetic and environmental contexts, making them attractive targets for further investigation. By facilitating rapid, efficient large-scale functional genomics assays across diverse genetic backgrounds, CRISPRi pooled screening will open new frontiers in C. albicans biology.
Insights
Researchers adapted pooled CRISPRi screening for large-scale analysis of essential genes in Candida albicans. This identified novel antifungal drug targets sensitive to inhibition across various conditions and resistant strains.
Area of Science:
- Mycology
- Genomics
- Drug Discovery
Background:
- Rising drug-resistant fungal infections pose a significant global health threat.
- Developing new antifungals is challenging due to evolutionary similarities between fungi and mammals, risking toxic side effects.
- Fungal-specific proteins are preferred drug targets, ideally mediating essential processes and showing high sensitivity to inhibition.
Purpose of the Study:
- To adapt pooled CRISPR interference (CRISPRi) screening for high-throughput functional genomics in *Candida albicans*.
- To identify essential, fungal-specific genes with high dosage sensitivity as potential antifungal drug targets.
- To investigate the influence of environmental conditions and resistant clinical isolates on gene dosage sensitivity.
Main Methods:
- Adapted pooled CRISPRi screening for *Candida albicans* to enable large-scale functional genomic analysis.
- Tested repression sensitivity of over 100 essential, conserved fungal genes absent in humans.
- Evaluated gene dosage sensitivity across ten diverse environmental conditions and two drug-resistant *C. albicans* clinical strains.
Main Results:
- Successfully identified numerous highly dosage-sensitive genes involved in various cellular components and pathways.
- Demonstrated that environmental conditions significantly alter gene dosage-sensitivity profiles.
- Confirmed that observed fitness defects in essential genes are largely conserved in drug-resistant clinical isolates.
Conclusions:
- Pooled CRISPRi screening is a powerful tool for rapid, efficient functional genomics in *Candida albicans*.
- Identified a set of highly dosage-sensitive genes across diverse genetic and environmental contexts, representing promising antifungal targets.
- This approach opens new avenues for antifungal drug development by facilitating the study of *C. albicans* biology and target identification.
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

